Loading…

The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart

The objective of this study was to define the relationship among AMP-activated protein kinase (AMPK) activity, AMP concentration ([AMP]), and [ATP] in perfused rat hearts. Bromo-octanoate, an inhibitor of β-oxidation, and amino-oxyacetate, an inhibitor of the malate-aspartate shuttle, were used to m...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2002-01, Vol.277 (3), p.1928-1932
Main Authors: Frederich, Markus, Balschi, James A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c478t-37d88cf01f6b8e51e3afa4cf5a0cd06f8119e3cba21849b4b7e1e2347f96d3813
cites cdi_FETCH-LOGICAL-c478t-37d88cf01f6b8e51e3afa4cf5a0cd06f8119e3cba21849b4b7e1e2347f96d3813
container_end_page 1932
container_issue 3
container_start_page 1928
container_title The Journal of biological chemistry
container_volume 277
creator Frederich, Markus
Balschi, James A.
description The objective of this study was to define the relationship among AMP-activated protein kinase (AMPK) activity, AMP concentration ([AMP]), and [ATP] in perfused rat hearts. Bromo-octanoate, an inhibitor of β-oxidation, and amino-oxyacetate, an inhibitor of the malate-aspartate shuttle, were used to modify substrate flux and thus increase cytosolic [AMP]. Cytosolic [AMP] was calculated using metabolites measured by 31P NMR spectroscopy. Rat hearts were perfused with Krebs-Henseleit solution containing glucose and either no inhibitor, the inhibitors, or the inhibitors plus butyrate, a substrate that bypasses the metabolic blocks. In this way, [AMP] changed from 0.2 to 27.9 μm, and [ATP] varied between 11.7 and 6.8 mm. AMPK activity ranged from 7 to 60 pmol·min−1·μg of protein−1. The half-maximal AMPK activation (A0.5) was 1.8 ± 0.3 μmAMP. Measurements in vitro have reported similar AMPKA0.5 at 0.2 mm ATP, but found thatA0.5 increased 10–20-fold at 4 mmATP. The low A0.5 of this study despite a high [ATP] suggests that in vivo the ATP antagonism of AMPK activation is reduced, and/or other factors besides AMP activate AMPK in the heart.
doi_str_mv 10.1074/jbc.M107128200
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71399365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820878120</els_id><sourcerecordid>71399365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-37d88cf01f6b8e51e3afa4cf5a0cd06f8119e3cba21849b4b7e1e2347f96d3813</originalsourceid><addsrcrecordid>eNp1kMFr2zAUh8XoWNNu1x2L6GE3Z3qWHcnHENq1rGWldLCbkOWnWcWxUklJ6H9fZQ70tHd5D_T9foiPkK_A5sBE9f25NfP7fEEpS8Y-kBkwyQtew58TMmOshKIpa3lKzmJ8ZnmqBj6RUwCRw1U9I_unHukjDjo5P8bebWiLaY840uX9Q6FNcjudsKMPwSd0I_3pRh2RLg8PLr1SPXYHkq78aHBM4V8PzWDKvbfRD1Mag93GfDzqRG9Qh_SZfLR6iPjluM_J7-urp9VNcffrx-1qeVeYSshUcNFJaSwDu2gl1oBcW10ZW2tmOrawEqBBblpdgqyatmoFApa8ErZZdFwCPyffpt5N8C9bjEmtXTQ4DHpEv41KAG8avqgzOJ9AE3yMAa3aBLfW4VUBUwfVKqtW76pz4OLYvG3X2L3jR7cZuJyA3v3t9y6gap03Pa5VKYTiCppSZkhOEGYJO4dBReMwu-xywCTVefe_D7wBmUaY4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71399365</pqid></control><display><type>article</type><title>The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart</title><source>ScienceDirect Journals</source><creator>Frederich, Markus ; Balschi, James A.</creator><creatorcontrib>Frederich, Markus ; Balschi, James A.</creatorcontrib><description>The objective of this study was to define the relationship among AMP-activated protein kinase (AMPK) activity, AMP concentration ([AMP]), and [ATP] in perfused rat hearts. Bromo-octanoate, an inhibitor of β-oxidation, and amino-oxyacetate, an inhibitor of the malate-aspartate shuttle, were used to modify substrate flux and thus increase cytosolic [AMP]. Cytosolic [AMP] was calculated using metabolites measured by 31P NMR spectroscopy. Rat hearts were perfused with Krebs-Henseleit solution containing glucose and either no inhibitor, the inhibitors, or the inhibitors plus butyrate, a substrate that bypasses the metabolic blocks. In this way, [AMP] changed from 0.2 to 27.9 μm, and [ATP] varied between 11.7 and 6.8 mm. AMPK activity ranged from 7 to 60 pmol·min−1·μg of protein−1. The half-maximal AMPK activation (A0.5) was 1.8 ± 0.3 μmAMP. Measurements in vitro have reported similar AMPKA0.5 at 0.2 mm ATP, but found thatA0.5 increased 10–20-fold at 4 mmATP. The low A0.5 of this study despite a high [ATP] suggests that in vivo the ATP antagonism of AMPK activation is reduced, and/or other factors besides AMP activate AMPK in the heart.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M107128200</identifier><identifier>PMID: 11707445</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetyl-CoA Carboxylase - metabolism ; Adenosine Monophosphate - metabolism ; Amino Acid Sequence ; AMP-Activated Protein Kinases ; Animals ; Caprylates - pharmacology ; Enzyme Inhibitors - pharmacology ; In Vitro Techniques ; Molecular Sequence Data ; Multienzyme Complexes - antagonists &amp; inhibitors ; Multienzyme Complexes - metabolism ; Myocardium - enzymology ; Myocardium - metabolism ; Nuclear Magnetic Resonance, Biomolecular ; Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors ; Protein-Serine-Threonine Kinases - metabolism ; Rats ; Rats, Sprague-Dawley</subject><ispartof>The Journal of biological chemistry, 2002-01, Vol.277 (3), p.1928-1932</ispartof><rights>2002 © 2002 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-37d88cf01f6b8e51e3afa4cf5a0cd06f8119e3cba21849b4b7e1e2347f96d3813</citedby><cites>FETCH-LOGICAL-c478t-37d88cf01f6b8e51e3afa4cf5a0cd06f8119e3cba21849b4b7e1e2347f96d3813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021925820878120$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3547,27922,27923,45778</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11707445$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Frederich, Markus</creatorcontrib><creatorcontrib>Balschi, James A.</creatorcontrib><title>The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>The objective of this study was to define the relationship among AMP-activated protein kinase (AMPK) activity, AMP concentration ([AMP]), and [ATP] in perfused rat hearts. Bromo-octanoate, an inhibitor of β-oxidation, and amino-oxyacetate, an inhibitor of the malate-aspartate shuttle, were used to modify substrate flux and thus increase cytosolic [AMP]. Cytosolic [AMP] was calculated using metabolites measured by 31P NMR spectroscopy. Rat hearts were perfused with Krebs-Henseleit solution containing glucose and either no inhibitor, the inhibitors, or the inhibitors plus butyrate, a substrate that bypasses the metabolic blocks. In this way, [AMP] changed from 0.2 to 27.9 μm, and [ATP] varied between 11.7 and 6.8 mm. AMPK activity ranged from 7 to 60 pmol·min−1·μg of protein−1. The half-maximal AMPK activation (A0.5) was 1.8 ± 0.3 μmAMP. Measurements in vitro have reported similar AMPKA0.5 at 0.2 mm ATP, but found thatA0.5 increased 10–20-fold at 4 mmATP. The low A0.5 of this study despite a high [ATP] suggests that in vivo the ATP antagonism of AMPK activation is reduced, and/or other factors besides AMP activate AMPK in the heart.</description><subject>Acetyl-CoA Carboxylase - metabolism</subject><subject>Adenosine Monophosphate - metabolism</subject><subject>Amino Acid Sequence</subject><subject>AMP-Activated Protein Kinases</subject><subject>Animals</subject><subject>Caprylates - pharmacology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>In Vitro Techniques</subject><subject>Molecular Sequence Data</subject><subject>Multienzyme Complexes - antagonists &amp; inhibitors</subject><subject>Multienzyme Complexes - metabolism</subject><subject>Myocardium - enzymology</subject><subject>Myocardium - metabolism</subject><subject>Nuclear Magnetic Resonance, Biomolecular</subject><subject>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp1kMFr2zAUh8XoWNNu1x2L6GE3Z3qWHcnHENq1rGWldLCbkOWnWcWxUklJ6H9fZQ70tHd5D_T9foiPkK_A5sBE9f25NfP7fEEpS8Y-kBkwyQtew58TMmOshKIpa3lKzmJ8ZnmqBj6RUwCRw1U9I_unHukjDjo5P8bebWiLaY840uX9Q6FNcjudsKMPwSd0I_3pRh2RLg8PLr1SPXYHkq78aHBM4V8PzWDKvbfRD1Mag93GfDzqRG9Qh_SZfLR6iPjluM_J7-urp9VNcffrx-1qeVeYSshUcNFJaSwDu2gl1oBcW10ZW2tmOrawEqBBblpdgqyatmoFApa8ErZZdFwCPyffpt5N8C9bjEmtXTQ4DHpEv41KAG8avqgzOJ9AE3yMAa3aBLfW4VUBUwfVKqtW76pz4OLYvG3X2L3jR7cZuJyA3v3t9y6gap03Pa5VKYTiCppSZkhOEGYJO4dBReMwu-xywCTVefe_D7wBmUaY4Q</recordid><startdate>20020118</startdate><enddate>20020118</enddate><creator>Frederich, Markus</creator><creator>Balschi, James A.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020118</creationdate><title>The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart</title><author>Frederich, Markus ; Balschi, James A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-37d88cf01f6b8e51e3afa4cf5a0cd06f8119e3cba21849b4b7e1e2347f96d3813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acetyl-CoA Carboxylase - metabolism</topic><topic>Adenosine Monophosphate - metabolism</topic><topic>Amino Acid Sequence</topic><topic>AMP-Activated Protein Kinases</topic><topic>Animals</topic><topic>Caprylates - pharmacology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>In Vitro Techniques</topic><topic>Molecular Sequence Data</topic><topic>Multienzyme Complexes - antagonists &amp; inhibitors</topic><topic>Multienzyme Complexes - metabolism</topic><topic>Myocardium - enzymology</topic><topic>Myocardium - metabolism</topic><topic>Nuclear Magnetic Resonance, Biomolecular</topic><topic>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frederich, Markus</creatorcontrib><creatorcontrib>Balschi, James A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frederich, Markus</au><au>Balschi, James A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2002-01-18</date><risdate>2002</risdate><volume>277</volume><issue>3</issue><spage>1928</spage><epage>1932</epage><pages>1928-1932</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>The objective of this study was to define the relationship among AMP-activated protein kinase (AMPK) activity, AMP concentration ([AMP]), and [ATP] in perfused rat hearts. Bromo-octanoate, an inhibitor of β-oxidation, and amino-oxyacetate, an inhibitor of the malate-aspartate shuttle, were used to modify substrate flux and thus increase cytosolic [AMP]. Cytosolic [AMP] was calculated using metabolites measured by 31P NMR spectroscopy. Rat hearts were perfused with Krebs-Henseleit solution containing glucose and either no inhibitor, the inhibitors, or the inhibitors plus butyrate, a substrate that bypasses the metabolic blocks. In this way, [AMP] changed from 0.2 to 27.9 μm, and [ATP] varied between 11.7 and 6.8 mm. AMPK activity ranged from 7 to 60 pmol·min−1·μg of protein−1. The half-maximal AMPK activation (A0.5) was 1.8 ± 0.3 μmAMP. Measurements in vitro have reported similar AMPKA0.5 at 0.2 mm ATP, but found thatA0.5 increased 10–20-fold at 4 mmATP. The low A0.5 of this study despite a high [ATP] suggests that in vivo the ATP antagonism of AMPK activation is reduced, and/or other factors besides AMP activate AMPK in the heart.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11707445</pmid><doi>10.1074/jbc.M107128200</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2002-01, Vol.277 (3), p.1928-1932
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_71399365
source ScienceDirect Journals
subjects Acetyl-CoA Carboxylase - metabolism
Adenosine Monophosphate - metabolism
Amino Acid Sequence
AMP-Activated Protein Kinases
Animals
Caprylates - pharmacology
Enzyme Inhibitors - pharmacology
In Vitro Techniques
Molecular Sequence Data
Multienzyme Complexes - antagonists & inhibitors
Multienzyme Complexes - metabolism
Myocardium - enzymology
Myocardium - metabolism
Nuclear Magnetic Resonance, Biomolecular
Protein-Serine-Threonine Kinases - antagonists & inhibitors
Protein-Serine-Threonine Kinases - metabolism
Rats
Rats, Sprague-Dawley
title The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A56%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Relationship%20between%20AMP-activated%20Protein%20Kinase%20Activity%20and%20AMP%20Concentration%20in%20the%20Isolated%20Perfused%20Rat%20Heart&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Frederich,%20Markus&rft.date=2002-01-18&rft.volume=277&rft.issue=3&rft.spage=1928&rft.epage=1932&rft.pages=1928-1932&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M107128200&rft_dat=%3Cproquest_cross%3E71399365%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-37d88cf01f6b8e51e3afa4cf5a0cd06f8119e3cba21849b4b7e1e2347f96d3813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71399365&rft_id=info:pmid/11707445&rfr_iscdi=true